Author:
Giannopoulou Efstathia,Nikolakopoulos Achilleas,Kotsirilou Dimitra,Lampropoulou Angeliki,Raftopoulou Sofia,Papadimitriou Evangelia,Theocharis Achilleas D.,Makatsoris Thomas,Fasseas Konstantinos,Kalofonos Haralabos P.
Funder
EOGE Oncological Research Fund
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry, medical,Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. D’Addario G, Felip E. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 Suppl 4:68–70.
2. Hammerschmidt S, Wirtz H. Lung cancer: current diagnosis and treatment. Dtsch Arztebl Int. 2009;106(49):809–18. quiz 19–20.
3. Reade CA, Ganti AK. EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biogeosciences. 2009;3:215–24.
4. Aita M, Fasola G, Defferrari C, Brianti A, Bello MG, Follador A, et al. Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer. Crit Rev Oncol Hematol. 2008;68(3):183–96.
5. Adamo V, Franchina T, Adamo B, Denaro N, Gambadauro P, Chiofalo G, et al. Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives. Cancer Biol Ther. 2009;8(3):206–12.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献